Document:

Form of Registration Rights Agreement

 EXHIBIT 4.2 
 FORM OF 
 REGISTRATION RIGHTS AGREEMENT  
 THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of
[                    ], 2009 by and among Abraxis Health, Inc. (the “Company”), a Delaware corporation, Dr. Patrick Soon-Shiong
(“PSS”) and certain stockholders of Abraxis BioScience, Inc., a Delaware corporation (“Abraxis”) receiving Common Stock in the Spin-off (each as defined below) who execute and deliver a counterpart to this Agreement
(collectively, the “Stockholder Parties”). 
 R E C I T A L S 
 A. Pursuant to a Registration Rights Agreement, dated as of November 13, 2007, among Abraxis, PSS and the Stockholder Parties (the
“Abraxis Registration Rights Agreement”), Abraxis granted the Stockholder Parties certain registration rights with respect to the common stock, par value $0.001, of Abraxis (the “Abraxis Common Stock”). 
 B. Pursuant to the terms of the Abraxis Registration Rights Agreement, the shares of Abraxis Common Stock received by the Stockholder
Parties that were party to the Abraxis Registration Rights Agreement became Registrable Securities, as defined under the terms of the Abraxis Registration Rights Agreement. 
 C. On the date hereof, Abraxis, the Company and certain of their subsidiaries are undertaking a series of transactions pursuant to which,
among other things, Abraxis will distribute all of the Company’s issued and outstanding Common Stock on a pro rata basis to the holders of record of shares of Abraxis Common Stock (the “Spin-off”). 
 D. Pursuant to the terms of the Abraxis Registration Rights Agreement, the shares of Common Stock received in the Spin-off by the holders
of Abraxis Common Stock who are Stockholder Parties will be Registrable Securities. As a result, the Company is entering into this Registration Rights Agreement with the Stockholder Parties to govern their registration rights over shares of Common
Stock. The Stockholder Parties’ registration rights with respect to shares of Abraxis Common Stock will continue to be governed by the terms of the Abraxis Registration Rights Agreement. 

 AGREEMENT 
 NOW, THEREFORE, in consideration of the foregoing and of the mutual promises herein contained, the parties hereby agree as follows: 
 1. Definitions. Unless the context otherwise requires, the terms defined in this Section 1 shall have the meanings herein specified for all purposes of this Agreement, applicable to both the singular and
plural forms of any of the terms herein defined. 
 “Agreement” means this Registration Rights Agreement. 
 “Automatic Shelf Registration Statement” means an automatic shelf registration statement as defined under Rule 405 of the Securities
Act. 
 “Board” means the Board of Directors of the Company. 
 “Common Stock” means the common stock, par value $0.001, of the Company. 
 “Commission” means the Securities and Exchange Commission. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 “Holder” of any security means the record or beneficial owner of such security. 
 “Holders of a Majority of Registrable Securities” means the Person or Persons who are the Holders of greater than 50% of the Registrable
Securities then outstanding. 
 “Independent Member of the Board” means members of the Board who are members of the
Company’s audit committee. 
 “Initiating Holder” means any Holder of Registrable Securities. 
 “Person” means any natural person, corporation, trust, association, company, partnership, limited liability company, joint venture and
other entity and any government, governmental agency, instrumentality or political subdivision. 
 The terms “register,”
“registered” and “registration” refer to a registration effected by preparing and filing a registration statement in substantial compliance with the Securities Act, and the declaration or ordering of the
effectiveness of such registration statement. 
 “Registrable Securities” shall mean (i) the shares of Common Stock
issued to the Stockholder Parties pursuant to the Spin-off and (ii) any shares of Common Stock or other securities issued or issuable in respect of the Common Stock or the other securities referred to in clause (i) above by way of a
spin-off, split-off, dividend or stock split or in connection with a combination of shares, reclassification, merger, consolidation or reorganization; provided, however, that such shares of Common Stock or other securities shall
constitute Registrable Securities only so long as they have not been (x) sold to or through a broker or dealer or underwriter in a public distribution or a public securities transaction pursuant to an effective registration statement under the
Securities Act, or (y) sold in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act under Section 4(1) thereof so that all transfer restrictions and restrictive legends with respect to such
Common Stock or other securities are removed upon the consummation of such sale and the seller and purchaser of such Common Stock or other securities receive an opinion of counsel for the Company, which 

  

 2 

 
shall be in form and content reasonably satisfactory to the seller and purchaser and their respective counsel, to the effect that such Common Stock or other
securities in the hands of the purchaser are freely transferable without restriction or registration under the Securities Act in any public or private transaction. 
 “Securities Act” means the Securities Act of 1933, as amended. 
 “WKSI”
means a well-known seasoned issuer as defined under Rule 405 of the Securities Act. 
 2. Underwritten Demand Registration.

 (a) At any time or from time to time after the date hereof, any Initiating Holder shall have the right to request, by delivery of a
written notice to the Company (an “Underwritten Demand Notice”), that the Company file a registration statement under the Securities Act (an “Underwritten Registration Statement”) covering all or a portion of the Registrable
Securities for the purpose of effecting an underwritten offering of such Registrable Securities (an “Underwritten Demand Registration”); provided, however, that no Initiating Holder shall be entitled to demand an Underwritten Demand
Registration Statement during the period when the Company is exercising its right to defer a Shelf Demand Registration pursuant to Section 3(b). Any such Underwritten Demand Notice must request the registration of Registrable Securities having
an aggregate market value, based on the volume weighted average per share trading price of the Registrable Securities as reported any other securities exchange, market or quotation system upon which the Registrable Securities are then traded) over
the ten (10) consecutive trading days prior to the date of the Underwritten Demand Notice, of not less than four million dollars ($4,000,000). Subject to Section 6(b)(A), as soon as reasonably practicable, but in no event later than
forty-five (45) days (thirty (30) days if the registration statement will be on Form S-3) after receiving an Underwritten Demand Notice, the Company shall file with the Commission a registration statement covering the Registrable
Securities subject to the Underwritten Demand Notice. Subject to Sections 2(b) and 4, the Company shall use its reasonable best efforts to cause such registration statement to become effective as expeditiously as possible. Any registration under
this Section 2 shall be on a form designated by the managing underwriter for such registration and the applicable registration statement shall reflect such plan or method of distribution of the applicable securities as shall be designated by
the managing underwriter. 
 (b) Notwithstanding the provisions of Section 2(a), if the Company is required to effect a registration
pursuant to this Section 2 and the Company furnishes to the Initiating Holder requesting such registration a certificate signed by the Chief Executive Officer of the Company or an Independent Member of the Board stating that in the good faith
judgment of the Board or a majority of the Independent Members of the Board it would be detrimental to the Company and its stockholders for a registration statement or other filing to be filed or become effective on or before the date such filing or
effectiveness would otherwise be required hereunder, the Company shall have the right to defer such filing or the effectiveness hereunder for a period ending not more than ninety (90) days after the Company’s receipt of the applicable
Underwritten Demand Notice, provided, that the Company may not exercise its right under this Section 2(b) more than twice in any 18-month period; and provided further, that the Company may not exercise its rights under this
Section 2(b) for two consecutive 90-day periods. 
  

 3 

 (c) Notwithstanding the provisions of Section 2(a), the Company shall not be obligated to
(i) file or effect an Underwritten Registration Statement within a period of 90 days after the effective date of any other Underwritten Registration Statement or an underwritten offering pursuant to a Shelf Registration Statement or
(ii) file or effect more than a total of two Underwritten Registration Statements within any 12-month period; provided, however, that each Shelf Registration Statement filed during the applicable 12-month period will reduce by one the number of
Underwritten Registration Statements the Company is obligated to file during such 12-month period. 
 (d) The Company may elect to register
in any Underwritten Demand Registration any additional shares of Common Stock (including, without limitation, any shares of Common Stock to be distributed in a primary offering made by the Company) so long as the inclusion of such Common Stock by
the Company would not (i) be reasonably likely to delay in any material respect the Initiating Holder’s ability timely to sell the Registrable Securities pursuant to the Demand Registration Statement or (ii) cause a reduction in the
number of Registrable Securities included in the Underwritten Demand Registration as a result of the Company’s election to so register additional shares of Common Stock. Such election of the Company, if made, shall be made by the Company giving
written notice to the Initiating Holder prior to the effectiveness of the Underwritten Registration Statement stating (A) that the Company proposes to include additional shares of Common Stock in such Demand Registration Statement, and
(B) the number of shares of Common Stock proposed to be included. 
 3. Shelf Registration. 
 (a) At any time or from time to time after the date hereof and so long as the Company is eligible to register Registrable Securities under a Form S-3
Registration Statement, any Initiating Holder shall have the right to request, by delivery of a written notice to the Company (a “Shelf Demand Notice”), that (i) the Company file a shelf registration statement (a “Shelf
Registration Statement”) pursuant to Rule 415 under the Securities Act covering all or a portion of the Registrable Securities to enable the resale on a delayed or continuous basis of such Registrable Securities (a “Shelf Demand
Registration”) or (ii) if the Company is a WKSI and has an outstanding effective Form S-3 Registration Statement, the Company file a post-effective amendment to such Form S-3 Registration Statement covering all or a portion of the
Registrable Securities; provided, however, that in any case the Company shall not be obligated to file or effect any Shelf Registration Statement (A) at any time that the amount of unsold Registrable Securities covered by all then effective
Shelf Registration Statements equals or exceeds seventeen percent of the then outstanding shares of Common Stock of the Company or (B) if the requested Shelf Registration Statement covers a number of Registrable Securities that, when added to
the amount of unsold Registrable Securities covered by all then effective Shelf Registration Statements would equal or exceed seventeen percent of the then outstanding shares of Common Stock of the Company; and provided, further that no Initiating
Holder shall be entitled to demand a Shelf Registration Statement during the period when the Company is exercising its right to defer an Underwritten Demand Registration pursuant to Section 2(b). Subject to Section 6(b)(A), as soon as
reasonably practicable, but in no event later than thirty (30) days after receiving a Shelf Demand Notice (or twenty (20) days if the Company is a WKSI and then has an effective Form S-3 Registration Statement), the Company shall file with
the Commission a Shelf Registration Statement on Form S-3 of the Commission or, if the Company 

  

 4 

 
is a WKSI and has an effective Form S-3 Registration Statement, a post-effective amendment thereto. Subject to Sections 3(b) and 3(c), the Company shall use
its commercially reasonable best efforts to cause the Shelf Registration Statement to become effective as expeditiously as possible and to remain effective until the earlier of (x) the time all Registrable Securities subject thereto have been
sold and (y) the third anniversary of the initial effective time, including by filing necessary post-effective amendments and prospectus supplements reasonably required by a Holder, subject to any blackout periods described in subparagraph
(b) below. If the Company is at any time a WKSI, it shall cause each Shelf Registration Statement to be, or shall cause any filed Shelf Registration Statement to be amended to be, an Automatic Shelf Registration Statement. The Initiating Holder
shall have the right to determine the plan and method of distribution for the Registrable Securities to be reflected in the Shelf Registration Statement in respect of which it is the Initiating Holder. 
 (b) Notwithstanding the provisions of Section 3(a), if the Company is required to effect a Shelf Registration Statement or make any filing with the
Commission pursuant to this Section 3 or if the Company has a Shelf Registration Statement in effect pursuant to this Section 3, and the Company furnishes to the Initiating Holder requesting such registration or filing or to the Holders of
Registrable Securities included in such Shelf Registration Statement, as applicable, a certificate signed by an Independent Member of the Board stating that (x) in the good faith judgment of a majority of the Independent Members of the Board it
would be detrimental to the Company and its stockholders for a registration statement or other filing to be filed on or before the date such filing would otherwise be required hereunder or (y) sales pursuant to a Shelf Registration Statement
would require the disclosure of information not otherwise then required by law (in the absence of a registration or sales thereunder) to be publicly disclosed and that in the good faith judgment of a majority of the Independent Members of the Board
such disclosure would be detrimental to the Company and its stockholders, the Company shall have the right to defer such filing or the effectiveness thereof for a period of not more than ninety days after the Company’s receipt of the applicable
Shelf Demand Notice or prevent Holders of Registrable Securities from selling Registrable Securities pursuant to an effective Shelf Registration Statement for a period of not more than ninety days after the Company delivers a written request to the
applicable Holder demanding that such Holder cease sales of securities under the Shelf Registration Statement (and during such period the Company shall not be obligated to file another Shelf Registration Period during the period such sales under an
effective Shelf Registration Statement are not allowed); provided, that the Company may not exercise its rights under this Section 3(b) more than twice in any 18-month period; and provided further, that the Company may not
exercise its rights under this Section 2(b) for two consecutive 90-day periods. 
 (c) Notwithstanding the provisions of
Section 3(a), the Company shall not be obligated to (i) file a Shelf Registration Statement within a period of 90 days after the effective date of any Underwritten Registration Statement or an underwritten offering pursuant to a Shelf
Registration Statement or (ii) file or effect more than a total of two Shelf Registration Statements within any 12-month period; provided, however, that each filing of an Underwritten Registration Statement during the 12-month period will
reduce by one the number of Shelf Registration Statements that the Company is obligated to file during such 12-month period. 
  

 5 

 (d) Upon the receipt by the Company of a Shelf Demand Notice, the Company shall give prompt written
notice to all Holders of Registrable Securities (other than the Initiating Holder) that a Shelf Registration Statement pursuant to this Section 3 is being effected. In the event that any such Holder delivers to the Company a written request
within fifteen (15) days after the delivery of such written notice to the Holder by the Company, to include in such Shelf Registration Statement Registrable Securities of the Holder the Company shall include such Registrable Securities in the
Shelf Registration Statement, including by means of a pre-effective or post-effective amendment thereto; provided, however, that if the inclusion of the Registrable Securities of such Holders in such registration statement would, in
the opinion of the Initiating Holders, be reasonably likely to delay in any material respect the Initiating Holder’s ability to timely sell the Registrable Securities pursuant to the Shelf Registration Statement, the Company shall not include
such Holders’ Registrable Securities in the Shelf Registration Statement without the prior written consent of the Initiating Holder. 
 (e) At any time or from time to time after the date hereof, any Initiating Holder shall have the right to request, by delivery of a written notice to the Company (a “Shelf Underwritten Demand Notice”), that the Company effect an
underwritten offering of all or a portion of the Registrable Securities included in an existing Shelf Registration Statement. Any such Shelf Underwritten Demand Notice must request an underwritten offering of Registrable Securities having an
aggregate market value, based on the volume weighted average per share trading price of the Registrable Securities as reported any other securities exchange, market or quotation system upon which the Registrable Securities are then traded) over the
ten (10) consecutive trading days prior to the date of the Underwritten Demand Notice, of not less than four million dollars ($4,000,000). Subject to Section 6(b)(A), as soon as reasonably practicable after receiving an Underwritten Demand
Notice, but in no event later than thirty (30) days after receiving a Shelf Underwritten Demand Notice, the Company shall file with the Commission such amendments to the applicable Shelf Registration Statements and such prospectus supplements
or other filings as are necessary in connection with the underwritten offering of the Registrable Securities subject to the Shelf Underwritten Demand Notice, subject to Sections 3(b) and Section 4. Any prospectus supplement or other filing with
the Commission including a plan or method of distribution of the securities subject to an underwritten offering pursuant to this Section 3 shall reflect the plan or method of distribution of such securities as shall be designated by the
managing underwriter of the offering. 
 (f) The Company may elect to register in any Shelf Registration Statement any additional shares of
Common Stock (including, without limitation, any shares of Common Stock to be distributed in a primary offering made by the Company) so long as the inclusion of such Common Stock by the Company would not (i) be reasonably likely to delay in any
material respect the Initiating Holder’s ability to timely sell the Registrable Securities pursuant to the Shelf Registration Statement or (ii) cause a reduction in the number of Registrable Securities included in the Shelf Demand
Registration as a result of the Company’s election to so register additional shares of Common Stock. Such election of the Company, if made, shall be made by the Company giving written notice to the Initiating Holder stating (A) that the
Company proposes to include additional shares of Common Stock in such Shelf Registration Statement, and (B) the number of shares of Common Stock proposed to be included. 
 4. Underwritten Offerings. 
  

 6 

 (a) The Initiating Holder shall have the right to select the book-running managers and the co-managers
(collectively, the “managing underwriter”) in connection with any underwritten offering pursuant to Section 2 or Section 3; provided, that the selection of the managing underwriter by the Initiating Holder shall be subject
to the reasonable approval of the Board. In connection with such underwritten offering, the Company and the Initiating Holder shall enter into an underwriting agreement with the underwriter or underwriters selected for such underwriting,
provided, that such underwriting agreement is in customary form, provides for customary compensation, expense reimbursement and indemnification, and otherwise is reasonably acceptable to the Initiating Holder and the Company. 
 (b) Upon the receipt by the Company of an Underwritten Demand Notice or a Shelf Underwritten Demand Notice, the Company shall give prompt written notice
to all Holders of Registrable Securities (other than the Initiating Holder) that an underwritten offering pursuant to Section 2 or Section 3, as applicable is being effected. In the event that any such Holder delivers to the Company,
within fifteen (15) days after the delivery of such written notice to the Holder by the Company, a written request to include in such underwritten offering any Registrable Securities of the Holder, the Company shall include such Registrable
Securities in the registration statement; provided that the Company need not include in an underwritten offering pursuant to Section 3 any Registrable Securities that are not then included in the applicable Shelf Registration Statement
(unless the Company is then a WKSI). The right of any Holder to include Registrable Securities in any underwritten offering shall be conditioned upon such Holder’s willingness to enter into an underwriting agreement with the underwriter or
underwriters selected for such offering (in each case, unless otherwise mutually agreed by such Holder, the Initiating Holders and the Company). 
 (c) Notwithstanding the foregoing, if the managing underwriter of an underwritten offering in connection with any registration pursuant to Section 2 or Section 3 advises the Company and the Holders of Registrable Securities
participating in such offering in writing that in its good faith judgment the number of Registrable Securities requested to be included in such offering exceeds the number of Registrable Securities which can be sold in such offering at a price
acceptable to the applicable Initiating Holder, then (i) the number of Registrable Securities so requested to be included in such offering shall be reduced to that number of shares which in the good faith judgment of the managing underwriter
can be sold in such offering at such price and (ii) this reduced number of Registrable Securities shall be allocated among all Holders of Registrable Securities in proportion, as nearly as practicable, to the respective number of shares of
Registrable Securities then held by such Holders. 
 (d) Those Registrable Securities which are excluded from an underwriting in connection
with any registration pursuant to Section 2 or Section 3 hereof by reason of the managing underwriter’s marketing limitation and all other Registrable Securities not originally requested to be so included shall not be included in such
offering and shall be withheld from the market by the Holders thereof for a period (not to exceed ninety (90) days) which the managing underwriter reasonably determines is necessary to effect the underwritten offering. 
 (e) If the managing underwriter has not limited the number of Registrable Securities to be included in an underwritten offering pursuant to
Section 2 or Section 3, the Company and, subject to the requirements of Section 8 hereof, the other holders of the Company’s securities may include securities for its (or their) own account in such registration if 

  

 7 

 
the managing underwriter so agrees and if the number of Registrable Securities which would otherwise have been included in such offering will not thereby be
limited. 
 5. Piggyback Registration. 
 (a) Each time the Company shall determine to file a registration statement under the Securities Act (other than on Form S-4 or Form S-8 or a registration statement on Form S-1 or Form S-3 covering solely an employee
benefit plan) in connection with the proposed offer and sale of any of its securities of the same class as the Registrable Securities either for its own account or on behalf of any other security holder (other than a registration pursuant to
Section 2 or Section 3), the Company agrees to give prompt written notice of its determination to all Holders of Registrable Securities. In the event that any such Holder delivers to the Company, within fifteen (15) days after the
delivery of such written notice to the Holder by the Company, a written request to include in such registration statement any Registrable Securities of the Holder, the Company shall include such Registrable Securities in such registration statement,
all to the extent required to permit the sale or other disposition by the prospective seller or sellers of the Registrable Securities to be so registered. 
 (b) If the registration of which the Company gives written notice pursuant to Section 5(a) is for a public offering involving an underwriting, the Company shall so advise the Holders as a part of its written
notice. In such event the right of any Holder to registration pursuant to this Section 3 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the
underwriting to the extent provided herein. Holders proposing to distribute their Registrable Securities through such underwriting agree to enter into (together with the Company and the other Holders distributing their securities through such
underwriting) an underwriting agreement with the underwriter or underwriters selected for such underwriting by the Company. 
 (c)
Notwithstanding any other provision of this Section 5, if the managing underwriter of an underwritten offering in connection with the registration pursuant to this Section 5 advises the Company and the Holders of the Registrable Securities
participating in such registration in writing that in its good faith judgment the number of Registrable Securities and the other securities requested to be registered (i) exceeds the number of Registrable Securities and other securities which
can be sold in such offering at a price acceptable to the Company, or (ii) would jeopardize the success of the offering, then (A) the number of Registrable Securities and other securities proposed to be included in the offering shall be
reduced to that number which in the good faith judgment of the managing underwriter can be sold in such offering at a price acceptable to the Company and (B) such reduced number shall be allocated: 
  

	 	A.	If the registration is on behalf of the Company: 

  

	 	a.	First, to the Company, such that all securities proposed to be registered by or on behalf of the Company are included in the registration statement; 

  

	 	b.	Next, among all Holders of Registrable Securities in proportion, as nearly as practicable to the respective number of Registrable Securities held by such Holders at the time of the
filing of the registration statement; and 

  

 8 

	 	c.	Last, among all other participating holders proposing to register securities other than Registrable Securities, in the manner determined by the Company. 

  

	 	B.	If the registration is on behalf of holders of Common Stock other than any Stockholder Party: 

  

	 	a.	First, among all participating holders other than any Stockholder Party in the manner determined by the Company and among all Holders of Registrable Securities in proportion, as
nearly as practicable to the respective number of Registrable Securities and other shares of Common Stock held by such persons at the time of the filing of the registration statement; and 

  

	 	b.	Last, to the Company, for such number of shares of Common Stock as may be included in the registration statement. 

 (d) Those Registrable Securities which are excluded from the underwriting by reason of the managing underwriter’s marketing limitation and all other
Registrable Securities not originally requested to be so included shall not be included in such registration. 
 6. Registration
Procedures. If and whenever the Company is required by the provisions of Section 2 or 3 to effect the registration of Registrable Securities under the Securities Act, 
 (a) the Company, at its expense and as expeditiously as possible shall use its reasonable best efforts to effect such registration and agrees to:

 (A) in accordance with the Securities Act and all applicable rules and regulations, prepare and file with the Commission a registration
statement with respect to such securities and use its reasonable best efforts to cause such registration statement to become and remain effective for a period of 120 days (unless the registration is a Shelf Registration Statement in which case such
period shall extend until the earlier of (x) the time all Registrable Securities subject thereto have been sold and (y) the third anniversary of the initial effectiveness thereof, subject to the Company’s rights to cause Holders of
Registrable Securities to cease sales under an effective Shelf Registration Statement pursuant to Section 3(b)), and prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus
contained therein as may be necessary to keep such registration statement effective and such registration statement and prospectus accurate and complete and to permit the Holders of Registrable Securities subject to such registration statement to
sell such securities; 
 (B) if an offering is to be underwritten in whole or in part, enter into a written underwriting agreement in form and
substance reasonably satisfactory to the Company, the managing underwriter of the offering and to the Initiating Holder (in the case of a underwritten offering pursuant to Section 2 or Section 3) or to Holders of a majority of the
Registrable Securities participating in such offering (in the case of a registration pursuant to Section 3); 
 (C) furnish to the
Holders of securities participating in such registration and to the underwriters of the securities being registered such number of copies of the 

  

 9 

 
registration statement and each amendment and supplement thereto, preliminary prospectus, final prospectus, prospectus supplement and such other documents as
such underwriters and Holders may reasonably request; 
 (D) use its reasonable best efforts to register or qualify the securities covered by
such registration statement under such state securities or blue sky laws of such jurisdictions as such participating Holders of Registrable Securities and underwriters may reasonably request, except that the Company shall not for any purpose be
required to execute a general consent to service of process or to qualify to do business as a foreign corporation in any jurisdiction where it is not so qualified; 
 (E) notify the Holders of Registrable Securities participating in such registration, promptly after it shall receive notice thereof, of the date and time when such registration statement and each post-effective
amendment thereto has become effective or a prospectus or supplement to any prospectus relating to a registration statement has been filed; 
 (F) notify such Holders of Registrable Securities promptly of any request by the Commission for the amending or supplementing of such registration statement or prospectus or for additional information; 
 (G) prepare and file promptly with the Commission, and promptly notify such Holders of Registrable Securities of the filing of, such amendments or
supplements to such registration statement or prospectus as may be necessary to correct any statements or omissions if, at the time when a prospectus relating to such securities is required to be delivered under the Securities Act, when any event
has occurred as the result of which any such prospectus or any other prospectus as then in effect would include an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein not misleading; 
 (H) in case any of such Holders of Registrable Securities or any underwriter for any such Holders is
required to deliver a prospectus at a time when the prospectus then in circulation is not in compliance with the Securities Act or the rules and regulations of the Commission, the Company shall use reasonable best efforts to prepare promptly upon
request such amendments or supplements to such registration statement and such prospectus as may be necessary in order for such prospectus to comply with the requirements of the Securities Act and such rules and regulations; 
 (I) advise such Holders of Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order
by the Commission suspending the effectiveness of such registration statement or the initiation or threatening of any proceeding for that purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its
withdrawal if such stop order should be issued; 
 (J) at the request of any Holder of Registrable Securities covered by such registration
statement, (i) furnish to such Holder on the effective date of the 

  

 10 

 
registration statement, upon the filing of a prospectus supplement with respect to such registration statement or, if such registration includes an
underwritten offering, at the closing provided for in the underwriting agreement, an opinion dated such date of the counsel representing the Company for the purposes of such registration, addressed to the underwriters, if any, and to the Holder or
Holders making such request, covering such matters with respect to the registration statement, the prospectus and each amendment or supplement thereto, proceedings under state, federal and other securities laws, other matters relating to the
Company, the securities being registered and the offer and sale of such securities as are customarily the subject of opinions of issuer’s counsel provided to underwriters in underwritten public offerings, and such opinion of counsel shall
additionally cover such legal matters with respect to the registration as such requesting Holder or Holders may reasonably request, and (ii) use its reasonable best efforts to furnish to such Holders letters dated each of such effective date,
the date of the filing of a prospectus supplement and such closing date, from the independent certified public accountants of the Company, addressed to the underwriters, if any, and to the Holder or Holders making such request, stating that they are
independent certified public accountants within the meaning of the Securities Act and dealing with such customary matters as the underwriters may request, or if the offering is not underwritten that in the opinion of such accountants the financial
statements and other financial data of the Company included in the registration statement or the prospectus or any amendment or supplement thereto comply in all material respects with the applicable accounting requirements of the Securities Act, and
additionally covering such other accounting and financial matters as such requesting Holder or Holders may reasonably request; 
 (K) list the
Registrable Securities (and to maintain such listing during the pendency of the relevant registration period) on any exchange, market or quotation system on which the securities of the Company of the same class with Registrable Securities are listed
(and to maintain such qualification during the pendency of the relevant registration period); 
 (L) make senior executives of the Company
available, upon reasonable prior notice and subject to reasonable scheduling flexibility, to assist the underwriters with respect to, and to accompany the underwriters on the so-called “road show” in connection with, marketing efforts for
the distribution and sale of Registrable Securities pursuant to an underwritten offering so long as the fulfillment of this Section 6(a)(L) shall not materially impair such senior executives’ management of the Company and other activities
on behalf of the Company and so long as any related expenses (including, without limitation, expenses of the Company and participating senior executives) not required to be paid by the Company pursuant to Section 7(b) are paid by the Holders
requesting such “road show” participation and assistance; and 
  

 11 

 (M) prepare other offering materials in a form customarily used in similar transactions or on the request
of any Holder of Registrable Securities or any managing underwriter. 
 (b) Each Holder of Registrable Securities included for registration,
at its expense and as expeditiously as possible agrees to: 
 (A) provide the Company with such information and assistance as reasonably
requested by the Company to effect such registration under the Securities Act; and 
 (B) keep confidential that the Company has exercised its
rights under Sections 2(b), 3(b) and any other confidential information provided by the Company in connection with this Agreement. 
 (c)
Certain legal consequences arise from being named as a selling securityholder in a registration statement and related prospectus. Accordingly, each Stockholder Party acknowledges that it has been advised to consult its own independent securities law
counsel regarding the consequences of demanding or requesting registration of Registrable Securities hereunder or being named or not being named as a selling securityholder in the registration statement and related prospectus. 
 7. Expenses. 
 (a) With respect to
each inclusion of shares of Registrable Securities in a registration statement pursuant to Section 2 or Section 3, the Company agrees to bear all fees, costs and expenses of such registration and any public offerings in connection
therewith; provided, however, that Holders participating in any such registration agree to bear their pro rata share of the underwriting discount and commissions, and any the expenses associated or incurred in connection with
“road show” or other marketing efforts the expenses of which are not required to be paid by the Company pursuant to subparagraph (b) below shall be paid by the Holders of Registrable Securities requesting the same. 
 (b) The fees, costs and expenses of registration to be borne as provided in paragraph (a) above, shall consist of (i) all registration, filing
and NASD [FINRA?] fees, printing expenses, fees and disbursements of counsel and accountants for the Company, (ii) fees and disbursements of counsel for the underwriter(s) of such securities (if the Company and/or selling security holders are
otherwise required to bear such fees and disbursements), (iii) all legal fees and disbursements and other expenses of the Company complying with state securities or blue sky laws of any jurisdictions in which the securities to be offered are to
be registered or qualified, (iv) reasonable fees and disbursements of one firm of counsel for the selling security holders designated by the Holders of a majority of the Registrable Securities included in such registration, and (v) the
expenses associated with the “road show” or other marketing efforts for the distribution and sale of Registrable Securities registered under two underwritten registration statements filed pursuant to either Section 2 or 3 in any
eighteen month period. 
 (c) Notwithstanding the foregoing, the Company shall pay the expenses of a registration statement requested
pursuant to Section 2 or Section 3 only with respect to the first eight (8) registration statements so filed (and then only to the extent provided in Section 7) and all expenses related to any additional registration statements,
including those fees and expenses 

  

 12 

 
set forth in Section 7(b), shall be paid by the Initiating Holder and/or the Holders of Registrable Securities on a pro rata basis; provided
that, in the event that a registration pursuant to Section 2 or 3 is requested by an Initiating Holder and such request is withdrawn prior to the filing of a registration statement by the Company, or the Holders of Registrable Securities cause
the Company to withdraw a registration statement prior to its effectiveness, then either (at the election of the Initiating Holder), (i) the Initiating Holder and other Holders of Registrable Securities requesting inclusion of their shares in
such registration shall bear pro rata all fees, costs and expenses of the registration and preparation of the registration statement and such requested registration statement shall not be deemed to be one of the registration statements for which the
Company is required to pay expenses pursuant to this Section 7, or (ii) such requested registration statement shall be deemed to be one of the registration statements for which the Company is required to pay the expenses pursuant to this
Section 7; provided, further, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company as of the date of their request for such
registration statement not known to the Initiating Holder or publicly available at the time of its request and have withdrawn their request solely on such basis and with reasonable promptness after learning of such material adverse change, then the
Holders shall not be required to pay any of such expenses and such requested registration statement shall not be deemed to be one of the registration statements for which the Company is required to pay expenses pursuant to this Section 7.

 8. Indemnification. 
 (a) The Company hereby agrees to indemnify and hold harmless each Holder of Registrable Securities which are included in a registration statement pursuant to the provisions of this Agreement and each of such Holder’s officers,
directors, partners, members, legal counsel and accountants, and each Person who controls such Holder within the meaning of the Securities Act and any underwriter (as defined in the Securities Act) for such Holder, and any Person who controls such
underwriter within the meaning of the Securities Act, from and against, and agrees to reimburse such Holder, its officers, directors, partners, members, legal counsel, accountants and controlling Persons and each such underwriter and controlling
Person of such underwriter with respect to, any and all claims, actions (actual or threatened), demands, losses, damages, liabilities, costs and expenses to which such Holder, its officers, directors, partners, members, legal counsel, accountants or
controlling Persons, or any such underwriter or controlling Person of such underwriter who may become subject under the Securities Act or otherwise, insofar as such claims, actions, demands, losses, damages, liabilities, costs or expenses arise out
of or are based upon (i) any untrue statement or alleged untrue statement of any material fact contained in such registration statement, any prospectus related thereto, or any amendment or supplement thereto, (ii) the omission or alleged
omission to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading or (iii) any violation or alleged violation by the Company of the Securities Act, the
Exchange Act, any federal or state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any federal or state securities law in connection with the offering covered by such registration statement;
provided, however, that the Company will not be liable to any such Person to the extent that any such claim, action, demand, loss, damage, liability, cost or expense is caused by an untrue statement or alleged untrue statement or
omission or alleged omission of material fact so made in strict conformity with written information furnished by such 

  

 13 

 
Holder or another Holder, such underwriter or such controlling Person specifically for use in the preparation thereof; provided, further, that
the Company shall not be liable to any such Person to the extent that such untrue statement or omission of material fact is subsequently corrected by an amendment or supplement to such registration statement (or an amended prospectus filed with the
Commission pursuant to Rule 424(b) of the Securities Act) and such amendment or supplement (or amended prospectus) is timely delivered to the Holders of Registrable Securities. 
 (b) Each Holder of shares of Registrable Securities which are included in a registration statement pursuant to the provisions of this Agreement hereby
agrees (severally and not jointly) to indemnify and hold harmless the Company, its officers, directors, legal counsel and accountants and each Person who controls the Company within the meaning of the Securities Act, from and against, and agrees to
reimburse the Company, its officers, directors, legal counsel, accountants and controlling Persons with respect to, any and all claims, actions, demands, losses, damages, liabilities, costs or expenses to which the Company, its officers, directors,
legal counsel, accountants or such controlling Persons may become subject under the Securities Act or otherwise, insofar as such claims, actions, demands, losses, damages, liabilities, costs or expenses are caused by any untrue or alleged untrue
statement of any material fact contained in such registration statement, any prospectus related thereto or any amendment or supplement thereto, or are caused by the omission or the alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission
or alleged omission was so made in reliance upon and in strict conformity with written information furnished by such Holder specifically for use in the preparation thereof; provided, however, that the indemnity agreement contained in
this subsection 6(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld or delayed;
provided, further, that the total amounts payable in indemnity by a Holder under this subsection 6(b) shall not exceed the net proceeds received by such Holder in the registered sale out of which such claim, action, demand, loss,
damage, liability, cost, or expense arises. 
 (c) Promptly after receipt by a party indemnified pursuant to the provisions of subsection
(a) or (b) of this Section 8 of notice of the commencement of any action involving the subject matter of the foregoing indemnity provisions, such indemnified party will, if a claim therefore is to be made against the indemnifying
party pursuant to the provisions of subsection (a) or (b), notify the indemnifying party of the commencement thereof; but the omission so to notify the indemnifying party will not relieve it from any liability which it may have to an
indemnified party otherwise than under this Section 6 and shall not relieve the indemnifying party from liability under this Section 6 unless such indemnifying party is prejudiced by such omission. In case any such action is brought
against any indemnified party, and it notifies the indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying parties
similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party; provided, however, that if the defendants in any such action include both the indemnified party and the indemnifying
party and the indemnified party shall have reasonably concluded that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, the indemnified

  

 14 

 
party or parties shall have the right to select separate counsel (in which case the indemnifying party shall not have the right to direct the defense of such
action on behalf of the indemnified party or parties). Upon the permitted assumption by the indemnifying party of the defense of such action, and approval by the indemnified party of counsel, the indemnifying party shall not be liable to such
indemnified party under subsection (a) or (b) for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof (other than reasonable costs of investigation) unless (i) the
indemnified party shall have employed separate counsel in connection with the assertion of legal defenses in accordance with the proviso to the next preceding sentence, (ii) the indemnifying party shall not have employed counsel reasonably
satisfactory to the indemnified party to represent the indemnified party within a reasonable time, (iii) the indemnifying party and its counsel do not actively and vigorously pursue the defense of such action, or (iv) the indemnifying
party has authorized the employment of counsel for the indemnified party at the expense of the indemnifying party. No indemnifying party shall be liable to an indemnified party for any settlement of any action or claim without the consent of the
indemnifying party and no indemnifying party may unreasonably withhold its consent to any such settlement. No indemnifying party will consent to entry of any judgment or enter into any settlement that does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability with respect to such claim or litigation. 
 (d) If the indemnification provided for in subsection (a) or (b) of this Section 8 is held by a court of competent jurisdiction to be unavailable to a party to be indemnified with respect to any claims, actions, demands,
losses, damages, liabilities, costs or expenses referred to therein, then each indemnifying party under any such subsection, in lieu of indemnifying such indemnified party thereunder, hereby agrees to contribute to the amount paid or payable by such
indemnified party as a result of such claims, actions, demands, losses, damages, liabilities, costs or expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party
on the other in connection with the statements or omissions which resulted in such claims, actions, demands, losses, damages, liabilities, costs or expenses, as well as any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. Notwithstanding the foregoing, the
amount any Holder of Registrable Securities shall be obligated to contribute pursuant to this subsection (d) shall be limited to an amount equal to the per share sale price (less any underwriting discount and commissions) multiplied by the
number of shares of Registrable Securities sold by such Holder pursuant to the registration statement which gives rise to such obligation to contribute (less the aggregate amount of any damages which such Holder has otherwise been required to pay in
respect of such claim, action, demand, loss, damage, liability, cost or expense or any substantially similar claim, action, demand, loss, damage, liability, cost or expense arising from the sale of such Registrable Securities). 
 (e) No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
hereunder from any person who was not guilty of such fraudulent misrepresentation. 
  

 15 

 (f) The obligations of the Company and Holders under this Section 8 shall survive the completion of
any offering of Registrable Securities in a registration statement and termination of this Agreement. 
 9. Stockholder Information.

 The Company may request each Holder of Registrable Securities as to which any registration is to be effected pursuant to this Agreement to
furnish the Company with such information with respect to such Holder and the distribution of such Registrable Securities as the Company may from time to time reasonably request in writing and as shall be required by law or by the Commission in
connection therewith, and each Holder of Registrable Securities as to which any registration is to be effected pursuant to this Agreement agrees to promptly furnish the Company with such information. 
 10. Forms. 
 All references in this
Agreement to particular forms of registration statements are intended to include, and shall be deemed to include, references to all successor forms which are intended to replace, or to apply to similar transactions as, the forms herein referenced.

 11. Lockup Agreement. 
 Each Holder of Registrable Securities agrees in connection with any registration of the Company’s securities that, upon the request of the managing underwriter of any underwritten offering of the Company’s securities (or, if there
is no managing underwriter, the Company), it or he or she shall not sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any capital stock of the Company (other than those that included in such
registration) without the prior written consent of such managing underwriter for a period not to exceed ninety (90) days. The Company may impose stop transfer instructions with respect to the Registrable Securities subject to the foregoing
restriction until the end of the lock-up period. 
 12. Transfer of Registration Rights. 
 The rights to cause the Company to register securities granted to the Holders of Registrable Securities pursuant to this Agreement may be transferred or
assigned only to (i) an affiliate or immediate family member of a Holder of Registrable Securities or (ii) an immediate or remote transferee of the Holder of Registrable Securities who, after such transfer, is the Holder of not less than
5% of the number of shares of Registrable Securities outstanding as of the date of this Agreement; provided that the transferee first agrees in writing to be bound by the terms of this Agreement. 
 13. Miscellaneous. 
 13.1 Waivers
and Amendments. 
 (a) With the written consent of the Holders of a Majority of the Registrable Securities, the obligations of the
Company and the rights of the Holders of Registrable Securities under this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely), and
with the consent of the Company, when authorized by a majority of the Independent Members of the Board, may enter into a supplementary agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the
provisions of this Agreement or of any 

  

 16 

 
supplemental agreement or modifying in any manner the rights and obligations hereunder of the Holders of Registrable Securities and the Company;
provided, however, that no such waiver or supplemental agreement shall reduce the aforesaid proportion of Registrable Securities, the Holders of which are required to consent to any wavier or supplemental agreement, without the consent
of the Holders of all of the Registrable Securities. 
 (b) Upon the effectuation of each such waiver, consent or agreement of amendment or
modification, the Company agrees to give prompt written notice thereof to the Holders of the Registrable Securities who have not previously consented thereto in writing. 
 (c) Neither this Agreement nor any provision hereof may be changed, waived, discharged or terminated orally or by course of dealing, but only by a statement in writing signed by the party against which enforcement of
the change, waiver, discharge or termination is sought, except to the extent provided in this Section 13.1; provided, that in the case of the Company, that such change, waiver, discharge or termination has been approved by a majority of
the Independent Members of the Board. Specifically, but without limiting the generality of the foregoing, the failure of any party hereunder at any time or times to require performance of any provision hereof by the Company shall in no manner affect
the right of such party at a later time to enforce the same. No waiver by any party of the breach of any term or provision contained in this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing
waiver of any such breach, or a waiver of the breach of any other term or covenant contained in this Agreement. 
 13.2 Effect of Waiver
or Amendment. Each Holder of Registrable Securities acknowledges that by operation of Section 13.1 hereof the Holders of a Majority of the Registrable securities will, subject to the limitations contained in Section 13.1(b), have the
right and power to diminish or eliminate certain rights of such Holder under this Agreement. 
 13.3 Rights of Holders Inter Se. Each
Holder of Registrable Securities shall have the absolute right to exercise or refrain from exercising any right or rights which such Holder may have by reason of this Agreement or any Registrable Security, including, without limitation, the right to
consent to the waiver of any obligation of the Company under this Agreement and to enter into an agreement with the Company for the purpose of modifying this Agreement or any agreement effecting any such modification, and such Holder shall not incur
any liability to any other Holder with respect to exercising or refraining from exercising any such right or rights. 
 13.4 Notices.
All notices, requests or consents required or permitted under this Agreement shall be made in writing and shall be given to the other parties by personal delivery, registered or certified mail (with return receipt), overnight air courier (with
receipt signature) or facsimile transmission (with “answerback” confirmation of transmission), sent to such party’s addresses or telecopy numbers as are set forth below such party’s signatures to this Agreement, or such other
addresses or telecopy numbers of which the parties have given notice pursuant to this Section 13.4. Each such notice, request or consent shall be deemed effective upon the date of actual receipt, receipt signature or confirmation of
transmission, as applicable (or if given by registered or certified mail, upon the earlier of (i) actual receipt or (ii) three days after deposit thereof in the United States mail (with respect to addresses within the United States) or ten
(10)

  

 17 

 
days after deposit thereof in the United States mail (with respect to addresses outside of the United States). 
 13.5 Severability. Should any one or more of the provisions of this Agreement or of any agreement entered into pursuant to this Agreement be
determined to be illegal or unenforceable, all other provisions of this Agreement and of each other agreement entered into pursuant to this Agreement, shall be given effect separately from the provision or provisions determined to be illegal or
unenforceable and shall not be affected thereby. 
 13.6 No Third Parties. Subject to Section 8 hereof, this Agreement shall not
run to the benefit of or be enforceable by any Person other than a party to this Agreement or, with respect to the Company, any successor thereto. 
 13.7 Headings. The headings of the sections, subsections and paragraphs of this Agreement have been inserted for convenience of reference only and do not constitute a part of this Agreement. 
 13.8 Choice of Law. It is the intention of the parties that the internal substantive laws, and not the laws of conflicts, of the State of Delaware
should govern the enforceability and validity of this Agreement, the construction of its terms and the interpretation of the rights and duties of the parties. 
 13.9 Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same effect as if all parties had signed the same document. All
such counterparts shall be deemed an original, shall be construed together and shall constitute one and the same instrument. 
 13.10
Arbitration. 
 (a) Any and all disputes or controversies, whether of law or fact and of any nature whatsoever arising from or
respecting this Agreement, shall be decided by binding arbitration in accordance with Title 9 of the United States Code and the Commercial Arbitration Rules of the American Arbitration Association (the “Association”). If the parties are
unable to agree upon a single arbitrator, the arbitrator shall be a single, independent arbitrator selected by the Association. 
 (b)
Arbitration shall take place at Los Angeles, California, or any other location mutually agreeable to the parties. The decision of the arbitrator shall be final and binding upon all parties hereto and all persons claiming under and through them and
judgment thereon may be entered by any court of competent jurisdiction. The fees and expenses of the arbitrator shall be paid equally by the parties to such arbitration. 
 13.11 Rule 144. To the extent that the Company is subject to the filing and reporting requirements of the Securities Act and the Exchange Act, and so long as there are Registrable Securities outstanding, the
Company will file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder, make and keep public information available, as those terms are understood and defined
in Rule 144 under the Securities Act, and will take such further action as any holder of Registrable Securities may reasonably request, all to the extent required from time to time to enable such Holder to sell Registrable Securities without
registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 or Rule 144A under the 

  

 18 

 
Securities Act, as such Rule may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of
any holder of Registrable Securities, the Company will deliver to such holder a written statement as to whether it has complied with such information and requirements and with a copy of the most recent annual or quarterly report of the Company, and
such other reports and documents of the Company as a Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to sell any such securities without registration. 
 13.12 Entire Agreement. This Agreement contains the entire understanding of the parties hereto in respect of its subject matter and supersedes all
prior and contemporaneous agreements and understandings, oral and written, between the parties with respect to such subject matter. 
 [signature page follows] 
  

 19 

 REGISTRATION RIGHTS AGREEMENT SIGNATURE PAGE 
 IN WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly executed as of the date first above written. 
  

			
	ABRAXIS HEALTH, INC.
		
	By:	 	 
		 	 Name:
 Title:

 Address: 
 11755
Wilshire Boulevard 
 Suite 2000 
 Los Angeles, CA 90025

 Fax: (310) 883-3138 
 Attention: General Counsel

  

	
	PSS
	
	  
	Dr. Patrick Soon-Shiong

 Address: 
 c/o Abraxis
Health, Inc. 
 11755 Wilshire Boulevard 
 Suite 2000 

Los Angeles, CA 90025 
 Fax: (310) 883-3138 
 Stockholder Parties: 
  

			
	 CALIFORNIA CAPITAL LIMITED PARTNERSHIP
  
 By: Themba, LLC, its general partner

		
	By:	 	 
		 	 Name: Steven H. Hassan
 Title:
Manager

 Address: 

 Californian Capital Limited Partnership 
 Att: Steven H. Hassan 
 10182 Culver Boulevard 
 Culver City, California 90232 
 SOON-SHIONG COMMUNITY PROPERTY REVOCABLE TRUST 

			
		
	By:	 	 
		 	 Name:
 Title:

 Address: 
 Soon-Shiong
Community Property Revocable Trust 
 Att: Steven H. Hassan 
 10182 Culver Boulevard 
 Culver City, California 90232 
  

			
	RSU PLAN, LLC
		
	By:	 	 
		 	 Name: Steven H. Hassan
 Title:
Manager

 Address: 
 RSU Plan,
LLC 
 Att: Steven H. Hassan 
 10182 Culver Boulevard 

Culver City, California 90232Form of Transition Services Agreeement

 EXHIBIT 10.2 
 FORM OF 
 TRANSITION SERVICES AGREEMENT 
 THIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is entered into as of _______, 2009 (the “Effective
Date”), between ABRAXIS BIOSCIENCE, INC., a Delaware corporation (“ABI”), ABRAXIS BIOSCIENCE, LLC, a Delaware limited liability company (“AB LLC” and together with ABI, the
“ABI Parties”) and ABRAXIS HEALTH, INC., a Delaware corporation (“Health”). 
 Unless
otherwise provided, all cross references to Sections, Articles and Exhibits used herein shall refer to Sections, Articles and Exhibits of this Agreement. 
 RECITALS 
 WHEREAS, the ABI Parties and Health have entered into a Separation and Distribution
Agreement, dated as of the date hereof (the “Separation Agreement”), pursuant to which Health and the ABI Parties will become separate companies with Health and its Subsidiaries operating the SpinCo Business (both as defined
in the Separation Agreement) and the ABI Parties and their Subsidiaries operating the ABI Business (as defined in the Separation Agreement) (each a “Business” and collectively the “Businesses”); and

 WHEREAS, the parties to the Separation Agreement agreed to enter into a transition services agreement, substantially in the form
hereof, to ensure that the ABI Parties and Health and their respective Subsidiaries obtain certain support and administrative and other services for the purpose of assisting each other to manage an orderly separation of the Businesses; 

NOW, THEREFORE, the parties hereto agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 1.1 Certain Definitions. As used in this Agreement, the following terms shall have the meanings set forth below: 
 “ABI Parties Services” shall mean the Services identified in Exhibit A. 
 “Health
Services” shall mean the Services identified in Exhibit B. 
 “Service” shall mean, as applicable, a service included in the Health Services or the ABI Parties Services, provided, that the parties expressly acknowledge and agree that the term “Services” as used
in this Agreement shall not be deemed to include the provision of any service or the performance of any obligation under or in accordance with the nab® Technology License or the
Product License. Each service for which there is a separate itemized price in Exhibit A or Exhibit B shall be considered a separate Service. 
  

 1 

 1.2 Other Terms. Except as otherwise defined herein, all other capitalized terms used but not
defined in this Agreement shall have the same meanings given to such terms in the Separation Agreement. 
 ARTICLE II 
 SERVICES 
 2.1 Provision of the ABI
Parties Services by the ABI Parties. The ABI Parties or their Subsidiaries shall use commercially reasonable efforts to provide, or cause to be provided to, Health and its Subsidiaries each of the ABI Parties Services in a manner
consistent with the manner in which such ABI Parties Services were provided by ABI and its Subsidiaries prior to the Effective Date and consistent with ABI and its Subsidiaries’ provision of such Services for their own businesses. Except as
otherwise provided on Exhibit A, the ABI Parties Services shall be provided until such date as this Agreement specifies or, with regards to any specific ABI Parties Service, such specific ABI Parties Service is terminated in accordance with
the terms of Article VI. 
 2.2 Provision of Health Services by Health. Health or its Subsidiaries shall use
commercially reasonable efforts to provide, or cause to be provided to, the ABI Parties and their Subsidiaries each of the Health Services in a manner consistent with the manner in which such Health Services were provided by ABI and its Subsidiaries
prior to the Effective Time and consistent with Health and its Subsidiaries’ provision of such Services for their own business. Except as otherwise provided on Exhibit B, Health Services shall be provided until such date as this
Agreement specifies or, with regards to any specific Health Service, such specific Health Service is terminated in accordance with the terms of Article VI. 
 2.3 Cooperation. The parties acknowledge and agree that: (a) it is impracticable to create an exhaustive list of Services needed to facilitate an orderly transition of the Businesses and, accordingly,
Exhibits A and B present general outlines of the scope of the Services to be provided by the parties; and (b) the parties will act in good faith and reasonably cooperate with one another during the term hereof to facilitate an
orderly transition of the Businesses. 
 2.4 Technology Matters Related to Provision of Services. 
 (a) The parties agree that all rights to inventions (whether patentable or not), know-how, data,
technology and copyrights other than, as described in Section 2.4(c) below, any inventions (whether patentable or not), know-how, data, technology and copyrights that are the subject of the nab® Technology License and the Product License (collectively, “Technology”) that are conceived or reduced to practice by the ABI Parties or their Subsidiaries, on the one hand, and Health or its
Subsidiaries, on the other hand (in each case, a “Service Provider”), directly in connection with, and as a result of, the provision of Services under this Agreement by a Service Provider to Health or its Subsidiaries, on the
one hand, or the ABI Parties or their Subsidiaries, on the other hand (in each case, the “Service Receiver”) shall be owned by the Service Receiver, provided that the Service Receiver, has fully paid for such Services in
accordance with the terms and conditions of this Agreement. 
  

 2 

 (b) Effective upon receipt of payment in full for the relevant Services, the Service Provider hereby
assigns to the Service Receiver, all right, title and interest in such assigned Technology. The Service Provider shall, or if a Subsidiary of a party to this Agreement, the party hereto that such Service Provider’s parent shall cause the
Service Provider to, promptly execute and deliver to the Service Receiver, such further agreements, certificates and other documentation reasonably requested by, and necessary or desirable to evidence the assignment of such Technology to, the
Service Receiver,. 
 (c) The ABI Parties and Health acknowledge and agree that this
Section 2.4 is subject to (and shall be subservient to) the rights and obligations of the parties and their respective Subsidiaries, as applicable, under each of the nab®
Technology License and the Product License. Accordingly, in the event there is any conflict or inconsistency between this Section 2.4 and the terms and conditions of the nab®
Technology License or the Product License regarding ownership or any other rights in or to Technology or other intellectual property rights, then as between this Agreement, on the one hand, and the nab® Technology License and the Product License, on the other hand, the terms and conditions of the nab® Technology License and the Product License shall
govern and prevail. 
 ARTICLE III 
 PAYMENT FOR SERVICES 
 3.1 Pricing. Each ABI Parties Service provided by the ABI Parties or their Subsidiaries shall
be charged to and payable by Health at the fees for such Service determined in accordance with Exhibit A. Each Health Service provided by Health or its Subsidiaries shall be charged to and payable by the ABI Parties at the monthly fees for
such Service determined in accordance with Exhibit B. Any fees shall be prorated during the first month and last month (as applicable) the Services are provided. 
 3.2 Billing and Payment. Charges for each of the Services provided shall be billed on a monthly basis by the party providing the Service. Such charges shall reflect a party’s actual cost of providing a
Service based on full time equivalent employee costs (including salary, benefits and related overhead) for providing the Services, with either no markup or a markup of seven percent (7%), depending on the particular Service as specified on
Exhibit A or Exhibit B, as the case may be. The party receiving a Service shall remit the amount specified in any such bill within thirty (30) calendar days after its receipt thereof. 
 3.3 Disputes. In the event a dispute arises concerning a Service or payment of such Service, the parties shall meet and attempt in good faith to
resolve the dispute in accordance with the following procedure. Prior to filing a lawsuit, seeking relief in some other forum or withholding payment for a Service, a party must first notify the other party of the dispute by submitting in writing an
outline of its position regarding the dispute, attaching relevant documentation to support its position and requesting a meeting with the other party within thirty (30) days of such notice. In response, the other party shall submit to that
party an outline of its position, attaching relevant documentation to support its position, within thirty (30) days of its receipt of such notice. Responsible, authorized employees from each party shall then meet and 

  

 3 

 
attempt in good faith to resolve the dispute for at least thirty (30) days. If the dispute is not resolved within such thirty (30) day period, then
the party that originally raised the dispute may file a lawsuit. 
 ARTICLE IV 
 WARRANTIES AND LIABILITIES 
 4.1 Level of Performance. Each party shall
use commercially reasonable efforts to provide the Services (i) consistent with the manner in which such Services were provided by ABI and its Subsidiaries prior to the Effective Date and consistent with such party’s provisions of such
Services for its own business, (ii) in a professional manner consistent with industry standards and (iii) in accordance with the policies, procedures and practices in effect with respect to the Businesses prior to the Effective Date, with
such modifications after the Effective Date as are reasonably acceptable to both parties. 
 4.2 Disclaimer of All Other Warranties.
EXCEPT AS EXPRESSLY PROVIDED IN SECTION 4.1, EACH PARTY MAKES NO REPRESENTATIONS OR WARRANTIES (INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE) OR GUARANTIES OF ANY KIND, EXPRESS OR IMPLIED, WITH RESPECT TO ANY SERVICES
(OR ANY SERVICES PROVIDED BY THIRD PARTIES WITH WHOM A PARTY CONTRACTS IN CONNECTION WITH THE PERFORMANCE OF THE SERVICES) PROVIDED TO THE OTHER PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY EXHIBITS HEREOF. 
 4.3 Indemnification. 
 (a) The ABI
Parties shall, to the fullest extent permitted by law, jointly and severally indemnify, defend and hold harmless Health, its Subsidiaries, Affiliates, officers, directors, employees, agents (the “Health Indemnified Parties”)
and assigns against all claims, liabilities, damages, losses or expenses (“Damages”) that arise out of (i) the gross negligence, bad faith, intentional misconduct or intentional breach of this Agreement by an ABI Party,
or (ii) any claim by any Person who is not a party to this Agreement (or an Affiliate thereof) (a “Third Party Claim”) relating to or arising out of Health’s performance of this Agreement and not resulting from
Health’s gross negligence, bad faith, intentional misconduct or intentional breach of this Agreement. 
 (b) Health shall, to the
fullest extent permitted by law, indemnify, defend and hold harmless ABI, its Subsidiaries, Affiliates, officers, directors, members, employees, agents (the “ABI Indemnified Parties”) and assigns against all Damages that
arise out of (i) Health’s gross negligence, bad faith, intentional misconduct or intentional breach of this Agreement, or (ii) any Third Party Claim relating to or arising out of the ABI Parties’ performance of this Agreement and
not resulting from the gross negligence, bad faith, intentional misconduct or intentional breach by any ABI Party of this Agreement. 
 (c)
The procedure by which each of the parties to this Agreement performs its obligations under subsections (a) and (b) above shall be in accordance with Sections 5.4, 5.5, 

  

 4 

 
(excluding the last sentence of Section 5.5(a) of the Separation Agreement) and 5.6 of the Separation Agreement. 
 4.4 Limitation of Liability. NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN, NEITHER PARTY WILL BE LIABLE HEREUNDER UNDER ANY CONTRACT,
NEGLIGENCE, STRICT LIABILITY OR OTHER LEGAL OR EQUITABLE THEORY FOR ANY SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS FROM THE USE OF (OR INABILITY TO USE) THE SERVICES OR OTHERWISE IN
CONNECTION WITH, OR ARISING OUT OF, THIS AGREEMENT. 
 ARTICLE V 
 FORCE MAJEURE; SERVICE INTERRUPTION AND RESTORATION 
 5.1 Force Majeure. No party to this
Agreement shall be responsible for failure or delay in delivery of any Service, nor shall any party be responsible for failure or delay in receiving such Service, if caused by an act of God or public enemy, war, government acts or regulations, fire,
flood, embargo, quarantine, epidemic, labor stoppages beyond its reasonable control, accident, unusually severe weather or other cause similar or dissimilar to the foregoing beyond their control; provided, that such Service will be performed
or satisfied as soon as reasonably practicable after the termination of the relevant circumstances causing such failure or delay. 
 5.2
Service Interruption and Restoration. The parties recognize that from time to time disruptions in the Services may occur. If a disruption of any Service occurs, the providing party shall use commercially reasonable efforts to restore such
Services consistent with the manner in which Abraxis would have restored such Services prior to the Effective Date and consistent with such party’s restoration of such Services for its own business. No party shall be deemed in default of this
Agreement to the extent that such disruptions or any delay or failure in the performance of its obligations under this Agreement results from any cause beyond its reasonable control and without its fault or negligence, such as the events and
circumstances specified in Section 5.1. In the event of any such excused disruption or delay, (i) the non-performing party promptly shall advise the other party in writing of the circumstances causing the disruption or delay, (ii) the
non-performing party shall use commercially reasonable efforts, consistent with the manner in which Abraxis would have overcome such circumstances prior to the Effective Date and resume performance as promptly as commercially practicable and
(iii) the time for performance shall be extended for a period equal to the time lost by reason of the delay. In the event the providing party is excused from supplying any Service in accordance with the terms of this paragraph, the receiving
party shall be free to acquire such Services from any substitute source, at the receiving party’s expense, and with a reduction in any amounts otherwise due hereunder to the providing party for the Service being so substituted but without
further liability to the providing party, for the period (and, to the extent the receiving party acts reasonably under the circumstances in making such commitments and it was necessary to make such commitments, a period thereafter necessary to honor
reasonable commitments beyond the expiration of any disruption or delay) and to the extent reasonably necessitated by such non-performance. 
  

 5 

 5.3 Pro-Ration of Limited Resources for Services. If at any time the resources available to
provide a particular Service or Services are less than the aggregate demand of both parties for such Service or Services, the providing party shall allocate whatever resources and or products that are available to it necessary for the performance of
such Service or Services in good faith equitably between the providing party for its own account and the receiving party for the performance of the Service hereunder. 
 ARTICLE VI 
 TERMINATION 
 6.1 Term and Termination. The term of this Agreement shall be for thirty-six (36) months after the Closing Date, or such shorter or longer period as the parties indicate in Exhibit A or
B, provided, however, a party receiving Services shall have the right to terminate one or more of the Services at the end of a designated month by giving the other party at least thirty (30) days prior written notice of such
termination. Except as otherwise agreed and subject to Sections 5.2 and 5.3, each Service can only be terminated in whole, and partial termination of a Service is not permitted without the prior approval of the providing party not to be unreasonably
withheld or delayed. The parties shall cooperate with each other in good faith in their efforts to reasonably effect early termination of Services, including, where applicable, partial termination, and to agree in good faith upon appropriate
reduction of the charges hereunder in connection with such early termination. For the avoidance of doubt, a party may not terminate a particular Service that is necessary to provide another Service that has not been terminated. 
 6.2 Early Termination. Notwithstanding the foregoing, each of the ABI Parties and Health reserves the right to immediately terminate this
Agreement by providing written notice to the other in the event that the other party shall have (a) applied for or consented to the appointment of a receiver, trustee or liquidator; (b) admitted in writing an inability to pay debts as they
mature; (c) made a general assignment for the benefit of creditors; or (d) filed a voluntary petition, or have filed against it a petition, for an order of relief under the Federal Bankruptcy Code (as amended). 
 ARTICLE VII 
 MISCELLANEOUS 

7.1 Notices. All notices and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have
been given if (i) delivered in person (to the individual whose attention is specified below) or via facsimile (followed immediately with a copy in the manner specified in clause (ii) or (iii) hereof), (ii) sent by prepaid
first-class registered or certified mail, return receipt requested, or (iii) sent by recognized overnight courier service, as follows: 
 to the ABI Parties: 
 Abraxis BioScience, Inc. 
 Abraxis BioScience, LLC 
  

 6 

	 	

	 	

	 	

 Fax: [·]

 Attention: Chief Executive Officer 
 With a copy to: 
 Abraxis BioScience, Inc. 

	 	

	 	

	 	

 Attention: General Counsel 
 to Health: 
 Abraxis Health, Inc. 
 11755 Wilshire Boulevard 
 [Suite 2000] 
 Los Angeles, CA 90025 
 Fax: [·] 
 Attention: Chief Executive Officer 
 With a copy to: 
 Abraxis Health, Inc. 
 11755 Wilshire Boulevard 
 [Suite 2000] 
 Los Angeles, CA 90025 
 Fax: [•] 
 Attention: General Counsel 
 or to such other address as any party hereto may, from time to time, designate in a written notice given in like
manner. All notices and other communications hereunder shall be effective: (i) the day of receipt when delivered by hand, facsimile or overnight courier; and (ii) three business days from the date deposited in the mail in the manner
specified above. 
 7.2 Amendment; Waiver. Any provision of this Agreement may be amended or waived if, and only if, such amendment or
waiver is in writing and signed, in the case of an amendment, by Health and the ABI Parties, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by any party in exercising any right, power or
privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. Except as otherwise provided herein, the
rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law. 
  

 7 

 7.3 Assignment; Parties in Interest. This Agreement and all of its provisions shall be binding
upon and inure to the benefit of the respective successors and permitted assigns of the parties hereto, provided, however, neither the ABI Parties nor Health may assign or transfer any of its rights or obligations under this Agreement
without the prior written consent of the other party. Notwithstanding the foregoing, with the prior written consent of the other party, the providing party may use subcontractors to provide some or all of the Services. If the providing party
delegates any of its responsibilities under this Agreement to any of its Subsidiaries or uses subcontractors in the performance thereof, then the providing party shall remain fully responsible for the actions and inactions and performance of such
Subsidiary or subcontractor and such Subsidiary or subcontractor shall be deemed the providing party hereunder for purposes of defining its performance obligations. 
 7.4 No Partnership. No party hereto in any way or for any purpose shall be deemed by reason of this Agreement to be a partner of any other party hereto in the conduct of their respective Businesses or a joint
venturer or a member of a joint enterprise with such other party. Neither party shall have any right or authority, express or implied, to assume or create any obligation of any kind, or to make any representation or warranty, on behalf of the other
party or to bind the other party in any respect whatsoever. 
 7.5 Governing Law; Submission to Jurisdiction; Selection of Forum. THIS
AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO ITS PRINCIPLES OF CONFLICTS OF LAWS. THE PARTIES HEREBY CONSENT TO JURISDICTION AND VENUE IN THE STATE AND FEDERAL COURTS SITTING
IN THE STATE OF DELAWARE. 
 7.6 Confidentiality. The provisions set forth in this Section 7.6 shall survive the termination or
expiration of this Agreement. 
 (a) Definitions. In the course of discussing or carrying out their respective obligations under this
Agreement, either party (the “Disclosing Party”) may disclose Confidential Information (as hereinafter defined) to the other party (the “Receiving Party”). As used herein, “Confidential
Information” means all written and oral information concerning the Disclosing Party, its business, its Affiliates or the business of any of its Affiliates, whether prepared by the Disclosing Party, its advisors or otherwise, which is
provided by or on behalf of the Disclosing Party to the Receiving Party during the term of this Agreement. Confidential Information shall include, without limitation, technical, scientific, business, financial and other information, data, materials
and the like relating to drug applications, patent applications, products and proposed products, know-how, processes, proposed processes, formulations, manufacturing technology, contracts, clinical and preclinical data and dossiers, business
relationships, customers, suppliers, marketing strategies and the like, and any and all other information, data and materials. Notwithstanding anything preceding to the contrary, Confidential Information shall not include information which the
Receiving Party demonstrates (i) is or becomes available to the public other than as a result of a disclosure by the Receiving Party or its representatives; (ii) was available to the Receiving Party on a non-confidential basis prior to its
disclosure to the Receiving Party by the Disclosing Party or its representatives; (iii) is disclosed to the Receiving Party by a third party which received such information from the 

  

 8 

 
Disclosing Party with no restrictions on disclosure; or (iv) was in the Receiving Party’s possession at the time of the disclosure by the
Disclosing Party (as evidenced by written records) and was not acquired, directly or indirectly, from the Disclosing Party. 
 (b)
Non-Disclosure. Subject to Section 7.6(d) of this Agreement, for a period of seven (7) years from the termination or expiration of this Agreement, the Receiving Party shall not disclose any Confidential Information of the Disclosing
Party to any third party and shall not use such Confidential Information for purposes other than is required for its performance under this Agreement. 
 (c) Copies. Upon the termination or expiration of this Agreement, the Receiving Party shall return to the Disclosing Party (or destroy at the Disclosing Party’s sole discretion) all documents and other
materials provided by the Disclosing Party to the Receiving Party containing or reflecting any Confidential Information, without retaining any copies; provided, however, that the Receiving Party may retain one (1) copy of any Confidential
Information for recordkeeping purposes (but any Confidential Information not so returned or destroyed will remain subject to this Agreement). Upon request, the Receiving Party shall certify in writing to the Disclosing Party as to its compliance
with this Section 7.6(c). 
 (d) Notice of Legal Process. In the event that the Receiving Party is requested or required (by
subpoena, civil investigative demand or other process) to disclose any Confidential Information, the Receiving Party shall provide the Disclosing Party with prompt written notice of any such request or requirement. The Receiving Party agrees to use
its best efforts to cooperate with the Disclosing Party in any attempt by the Disclosing Party to obtain an appropriate protective order or other reliable assurance that confidential treatment shall be accorded the Confidential Information. If the
Receiving Party is compelled by any legal process to disclose Confidential Information, the Receiving Party may disclose only that portion of the Confidential Information which it is compelled to disclose. 
 7.7 Severability. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not
affect the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application thereof to any person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be
substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other persons
or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction. 

7.8 Entire Agreement. This Agreement constitutes and contains the entire and only existing and binding agreement between the ABI Parties and
Health concerning the subject matter hereof, and supercedes all prior and contemporaneous negotiations, agreements, proposed agreements and understandings, if any, between the parties concerning this Agreement or any of its provisions. 

 

 9 

 7.9 Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall be deemed an original, and all of which shall constitute one and the same agreement. 
 [The Remainder Of This Page Has
Intentionally Been Left Blank] 
  

 10 

 IN WITNESS WHEREOF, the parties have executed or caused this Transition Services Agreement to be
executed as of the date first written above. 
  

			
	ABRAXIS BIOSCIENCE, INC.
		
	By:	 	 
		 	 Name:
 Title:

			
	
	ABRAXIS BIOSCIENCE, LLC.
		
	By:	 	 
		 	 Name:
 Title:

			
	
	ABRAXIS HEALTH, INC.
		
	By:	 	 
		 	 Name:
 Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]